Breast cancer is influenced by a combination of genetic, environmental, and lifestyle factors. One of the primary risk factors is age, with the likelihood of developing breast cancer increasing as a woman gets older. Family history also plays a significant role; individuals with close relatives, such as a mother or sister, who have had breast cancer are at higher risk, particularly if genetic mutations like BRCA1 or BRCA2 are present. Other factors include early menstruation, late menopause, and hormone replacement therapy (HRT), all of which can elevate estrogen levels, contributing to cancer risk.
Lifestyle choices also impact the likelihood of developing breast cancer. Obesity, especially post-menopause, can increase estrogen levels stored in fat tissue, leading to higher risk. Additionally, excessive alcohol consumption and smoking are known contributors to breast cancer development. Ralista 60mg, available at Dosepharmacy, is often prescribed to help prevent osteoporosis in postmenopausal women, and may also offer benefits in reducing breast cancer risk due to its selective estrogen receptor modulation.
12